Upcoming Events
- World TB day celebrations 2023
- Notification for Direct Recruitment of Scientific Officer & Technical Officer - MGMARI
- Notification for Research Assistant in the Indian Council of Medical Research – Grant –in-aid Adhoc Project
- Selected Participants List for the DHR Training Program
- Ph.D application for the December Batch 2022 - 2023
Ongoing Research Calls
- Aubrey Sheiham Research Award
- Pre- and Postdoctoral Training Awards from Autism Science Foundation - 2023
- JDRF Diabetes Psychology Fellowship Program
- Sparrow Early Career Researcher Grant
- Going Global Partnerships Industry Academia Collaborative Grant
- The Inspiring Science Award 2023
- Summer Research Fellowship Programme for Students and Teachers 2023
- Overseas Visiting Doctoral Fellowship from SERB
- CIFAR Azrieli Global Scholars Program
- A step by step guide to conduct systematic reviews and Meta-Analysis
- State University Research Excellence (SERB SURE)
- European Research Council Grant
Research Highlights
The present study prioritizes withanolide F as a prospective COVID-19 (Coronavirus disease) therapeutic agent based on the observations. 1578 compounds fltered from 9596 phytochemicals were chosen for screening against the RBD of the native SARS-CoV-2 S protein. Based on the binding energy, Four phytochemicals, namely withanolide F, serotobenine, orobanchol, and gibberellin A51, were found to be potential RBD binders in native and all SARS-CoV-2 VOCs. Interestingly withanolide F exhibited lower binding energy (-10.84 to -8.56 kcal/mol) and better ligand efciency (-0.3 to -0.25) against all forms of RBD in native and VOCs.
Impact
7
Consultancy
10
High Impact Publications
2
International Collaboration
17
Extramural Submission
2
Extramural Awarded
3
International Workshop
2
Certificate Course
2
Training
